secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001641172-25-005511
Event type: debt
Sentiment:  negative
Materiality: 0.40
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma raises ~$180k via convertible notes and board loan; conversion at deep discounts
--------------------------------------------------------------------------------

- $55k face convertible note issued at $50k (original issue discount) to GS Capital Partners; conversion price $5.00, drops to $2.50 if stock below $4 for 5 days.
- $79.2k convertible note issued with 15% one-time interest; conversion at 65% of lowest trading price after default (35% discount).
- $63k AUD loan from board member at 12% interest, due June 30, 2025; all proceeds for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225005511/0001641172-25-005511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225005511/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer